MAT1A and metabolic dysfunction-associated steatotic liver disease: Methylation at FGFR2, CASP1 and MAT1A was validated by bisulfite pyrosequencing, and the findings were reproduced in the replication cohort composed of 19 patients with mild and 15 with advanced NAFLD.